Merck & Co. Inc. Unveils $1 Billion Investment in Delaware for New Cancer Drug Facility

Merck & Co. Inc. announces a $1 billion investment in a new Delaware facility to produce innovative drugs and a new Keytruda formulation, creating 4,500 jobs by 2030, aligning with...